NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Stock Market Sees Partial Recovery on April 23

The Indian stock market staged a partial recovery on April 23, after a gap down opening, with the benchmark Sensex rising 350 points from its day's low. The Nifty also reclaimed the 24,250-mark, marking a significant turnaround in the market.

At 10:15 am, the Sensex was down 434.41 points or 0.55% at 78,082.08, and the Nifty was down 99.45 points or 0.41% at 24,278.65. The market saw a significant shift in investor sentiment, with about 1,764 shares advancing, 1,650 shares declining, and 167 shares remaining unchanged.

Market Analysts Cite Value Buying as Key Reason for Recovery

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Value buying emerged as a key reason behind the market's partial recovery. According to VK Vijayakumar, Chief Investment Strategist at Geojit Investments Limited, the Indian market has seen a trend of the broader market outperforming, with no significant pressure from Foreign Institutional Investor (FII) selling. Instead, FII have been buying stocks in the mid and small-cap segments, leading to the outperformance of the broader market. This trend is likely to continue, with stock-specific action in response to earnings results.

Pharma Shares Drive Market Recovery

The Nifty Pharma index rose nearly 2.5% on April 23, driven by buying in pharma shares. Nomura reported that the India pharmaceuticals market continued to grow in double digits at 10.1% year-on-year in March. Most companies under the brokerage's coverage grew ahead of expectations during the month.

Top Gainers in Pharma Sector

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

CompanyGain
Dr. Reddy's Laboratoriesover 6%
Ciplaaround 3%
Sun Pharmaceutical Industriesaround 1.3%

The market's technical reason for the recovery was also attributed to the Nifty taking support at the 24,100 level and starting to move upwards.

Comparison of Market PerformanceSensexNifty
Opening Point78,082.0824,278.65
Change from Day's Low+350 points+99.45 points
Percentage Change-0.55%-0.41%

Investor Takeaway

Investors should expect the broader market to continue outperforming, driven by value buying and FII buying in mid and smallcap segments.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.